Lung Transplant Journeys – Patients & Caregivers
Instead of the usual, facilitator-led patient support group meeting that takes place on the first Tuesday of every month at 2:00PM ET, this session will instead feature a live webinar […]
Loading view.
Educational Forums
FIBRONEER-IPF – A Phase 3 Clinical Trial
Boehringer Ingelheim has enrolled the first patient in FIBRONEER-IPF, a Phase 3 clinical trial evaluating the efficacy, safety, and tolerability of BI 1015550, an investigational therapy for people with idiopathic […]
Oxygen 101 with VitalAire
During this presentation, registered respiratory therapists (RRTs) Kelsey Kress and Natalie Collins, representatives from VitalAire, will explain the different oxygen equipment and their uses, as well as answer any questions […]
Understanding ILD in Rheumatoid Arthritis, Scleroderma and Other Connective Tissue Disorders – Dr. Janet Pope
During this presentation, Dr. Janet Pope will let us know everything we need to know about interstitial lung disease in rheumatoid arthritis, scleroderma and other connective tissue diseases. More information […]
Paralympic Voices of Hope
Life is filled with bumps and things we wish we could change but the beauty of it is finding joy despite those things. In this webinar, you will hear from […]
Palliative Care for Interstitial Lung Disease: Exploring Cannabis – Dr. Rebecca Colman
During this presentation, Dr. Rebecca Colman will be presenting on palliative care and symptom management in ILD with the role of cannabis to alleviate symptoms. Dr. Rebecca Colman is […]
Advances in Myositis-Associated Lung Disease Treatment – Dr. Shane Shapera
During this presentation, Dr. Shane Shapera will present on the advances in myositis-associated lung disease treatment. More information to come.
Understanding Medical Assistance in Dying
While there are many pulmonary fibrosis patients who choose to die with dignity through a MAiD procedure, it is still pretty taboo subject among the community. During this webinar, Kelsey Goforth, from […]
BEACON-IPF – A Phase 2 Clinical Trial
BEACON-IPF is a randomized, double-blind, dose-ranging, placebo-controlled study to evaluate the efficacy and safety of bexotegrast (PLN-74809) for the treatment of idiopathic pulmonary fibrosis (IPF). Dr. Gregory P. Cosgrove, Medical […]